| Drug Name: | Nitrofurazone (59-87-0) |
|---|---|
| PubChem ID: | 5447130 |
| SMILES: | C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N |
| InchiKey: | IAIWVQXQOWNYOU-FPYGCLRLSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 198.138 |
| LogP | : | 0.19 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 123.76 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Thiamin Deficiency | Transketolase (P29401) | Nitrofurazone decreased the activity of erythrocyte transketolase (TK) and increased the activation of TK by thiamin pyrophosphate@which associate with development of thiamin deficiency. [ ADR Type 3 ] | The effect of nitrofurazone on the thiamin status of chickens |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category